These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24614146)

  • 1. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
    Aronow ME; Chew EY
    Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
    ; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
    Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
    Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
    JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional supplements for age-related macular degeneration.
    Krishnadev N; Meleth AD; Chew EY
    Curr Opin Ophthalmol; 2010 May; 21(3):184-9. PubMed ID: 20216418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
    Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
    JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background.
    Ramkumar HL; Tuo J; Shen DF; Zhang J; Cao X; Chew EY; Chan CC
    J Nutr; 2013 Jul; 143(7):1129-35. PubMed ID: 23677863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional supplementation and age-related macular degeneration.
    Olson JH; Erie JC; Bakri SJ
    Semin Ophthalmol; 2011 May; 26(3):131-6. PubMed ID: 21609225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
    ; Chew EY; SanGiovanni JP; Ferris FL; Wong WT; Agron E; Clemons TE; Sperduto R; Danis R; Chandra SR; Blodi BA; Domalpally A; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Friberg TR; Rosenfeld PJ; Toth CA; Bernstein P
    JAMA Ophthalmol; 2013 Jul; 131(7):843-50. PubMed ID: 23645227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
    Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration.
    García-Layana A; Recalde S; Hernandez M; Abraldes MJ; Nascimento J; Hernández-Galilea E; Olmedilla-Alonso B; Escobar-Barranco JJ; Zapata MA; Silva R; Caballero Arredondo M; Lopez-Sabater MC; Mendez-Martínez S; Pardiñas-Barón N; Calvo P; Fernández-Robredo P
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional supplementation in age-related macular degeneration.
    Coleman H; Chew E
    Curr Opin Ophthalmol; 2007 May; 18(3):220-3. PubMed ID: 17435429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
    Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
    Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
    JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
    ; Papudesu C; Clemons TE; Agrón E; Chew EY
    Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.